NCT02019940View on ClinicalTrials.gov

A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD)

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
PTSD
Interventions
DRUG

Riluzole

Trial Locations (1)

06516

Clinical Neuroscience Division, National Center for PTSD, West Haven

All Listed Sponsors
collaborator

National Center for PTSD

FED

lead

Yale University

OTHER

NCT02019940 - A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter